Ultromics Company
![](/files/companies/Ultromics.png)
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
Headquarters:
Oxford, Oxfordshire, United Kingdom
Industry:
Imaging
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
13
Funding Status:
Early Stage Venture
Technology:
HealthCare Administration
Last Funding Type:
Series B
Founded Date:
2017-01-01
Total Funding:
58824943
Last Funding Date:
2021-08-16